A Study of Guselkumab in Participants With Crohn's Disease and Ulcerative Colitis | MicrobiomeTrials← Back to trialsNCT07606339
A Study of Guselkumab in Participants With Crohn's Disease and Ulcerative Colitis
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-06-15Est. Completion: 2029-06-15
Enrollment target: 35 participants Other microbiome trials you might be interested in
Inflammatory Bowel DiseaseCrohn's DiseaseUlcerative Colitis
Background:
Inflammatory bowel disease (IBD) is a term used to describe disorders that cause long-term inflammation in …
Bethesda, United StatesEst. completion Jun 1, 2036
Inflammatory Bowel Disease
Crohn's Disease (CD) and Ulcerative Colitis (UC), collectively known as inflammatory bowel disease (IBD), are two of the…
Chicago, United StatesEst. completion Sep 1, 2026
Phase 4
Recruiting
This multicenter, randomized, controlled trial aims to evaluate the efficacy and safety of standard-dose tumor necrosis …
Guangzhou, ChinaEst. completion Dec 31, 2028